BidaskClub upgraded shares of Healthequity (NASDAQ:HQY) from a hold rating to a buy rating in a report released on Saturday morning.
Several other research analysts also recently commented on the company. Raymond James boosted their target price on Healthequity from $85.00 to $105.00 and gave the stock an outperform rating in a report on Monday, September 10th. Bank of America downgraded Healthequity from a buy rating to a neutral rating and boosted their target price for the stock from $84.00 to $105.00 in a report on Thursday, September 6th. They noted that the move was a valuation call. SunTrust Banks boosted their target price on Healthequity to $105.00 and gave the stock a buy rating in a report on Wednesday, September 5th. Cantor Fitzgerald boosted their target price on Healthequity from $68.00 to $80.00 and gave the stock a neutral rating in a report on Wednesday, September 5th. Finally, Citigroup reissued a buy rating and issued a $110.00 target price on shares of Healthequity in a report on Wednesday, September 5th. Four analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Healthequity currently has a consensus rating of Buy and a consensus price target of $93.08.
Shares of HQY opened at $88.69 on Friday. The company has a market capitalization of $5.50 billion, a PE ratio of 115.18, a price-to-earnings-growth ratio of 3.08 and a beta of 1.39. Healthequity has a one year low of $42.92 and a one year high of $101.58.
In other Healthequity news, VP Darcy G. Mott sold 4,000 shares of the company’s stock in a transaction on Monday, October 22nd. The stock was sold at an average price of $87.01, for a total transaction of $348,040.00. Following the transaction, the vice president now owns 92,500 shares of the company’s stock, valued at approximately $8,048,425. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In the last ninety days, insiders have sold 12,000 shares of company stock worth $1,027,400. Company insiders own 4.00% of the company’s stock.
A number of large investors have recently bought and sold shares of the business. Advisors Asset Management Inc. lifted its stake in shares of Healthequity by 57.4% in the 2nd quarter. Advisors Asset Management Inc. now owns 2,136 shares of the company’s stock valued at $160,000 after purchasing an additional 779 shares during the period. Meeder Asset Management Inc. acquired a new position in shares of Healthequity in the 3rd quarter valued at $172,000. Rockefeller Capital Management L.P. acquired a new position in shares of Healthequity in the 2nd quarter valued at $179,000. Cerebellum GP LLC acquired a new position in shares of Healthequity in the 3rd quarter valued at $185,000. Finally, Sawtooth Solutions LLC acquired a new position in shares of Healthequity in the 2nd quarter valued at $207,000. 96.35% of the stock is currently owned by hedge funds and other institutional investors.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Story: Compound Annual Growth Rate (CAGR)
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.